5/4/23: Overview of Sickle Cell Disease and Newer Therapies in Adults

Mentor:

Tomona Iso, PharmD, BCPS 
Assistant Professor
Loma Linda University School of Pharmacy

Description:

Sickle cell disease is still widely misunderstood and there is limited data regarding newer therapies for the management of sickle cell disease in adults. The current mainstay of therapy is hydroxyurea, which decreases severe painful episodes and hospitalizations. However, there are newer medication approved for sickle cell disease. For example, voxelotor has been shown to reduce hemoglobin sickling and hemolysis. Another newer medication crizanlizumab has also been shown to minimize sickle cell related pain episodes. This CE will provide education regarding the place in therapy for these newer agents, and which patients may benefit most from them.

Learning Objectives:

Upon successful completion of this knowledge-based course pharmacists should be able to:

1. Describe sickle cell disease and its complications
2. Recognize the guideline recommended mainstays of therapy to manage sickle cell disease
3. Recognize how individuals with sickle cell disease present clinically
4. Discuss the evidence regarding newer medications approved to manage sickle cell disease

Claim your CPE Credit

To obtain 1.0 contact hour of continuing pharmacy education credit (0.1 CEU), participants must participate in the live activities, and log on to the CEimpact website to complete the exam and evaluation.

1. Click on https://learn.ceimpact.com and login to CEImpact.
2. If you are new to the site, click on Create an account before logging in.
3. Enter the course code (provided at the end of the lecture) in the text box on the left of the screen and click Submit.
4. Click on My Courses (on the left of the screen) to locate the course.
5. Click on the course title to access the course.
6. Complete the exam (2 opportunities provided) and evaluation as prompted and click Submit.
7. The course will move to the Completed tab under My Courses.
8. The CPE Statement of Credit will be available on CPE Monitor, www.MyCPEMonitor.net.

CEimpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

0107-9999-23-181-L01-P |  0.1 CEUs/1.0 Hrs.

Faculty Disclosure:  Anna Peyton Navarrete has no relevant financial relationships with ineligible companies to disclose.
Off-label use of medications will not be discussed during this presentation.

Course Format:  Live Webinar

Target Audience:  Pharmacists

Financial Support:  None

Course Fee:  There is no cost for this course; includes course, course materials, and CPE credit submission to CPE Monitor.